These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9010881)

  • 1. Saliva as a specimen for therapeutic drug monitoring in pharmacies.
    Zuidema J; Höld KM; de Boer D; Maes RA
    Pharm World Sci; 1996 Dec; 18(6):193-4. PubMed ID: 9010881
    [No Abstract]   [Full Text] [Related]  

  • 2. [Posology and therapeutic follow-up of drugs].
    Soins; 1998 Sep; (628):57-8. PubMed ID: 9823268
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacy-based therapeutic drug monitoring.
    Knowlton CH; Zarus SA; Voltis O
    Am Pharm; 1993 Jul; NS33(7):57-64; quiz 65-6. PubMed ID: 8342499
    [No Abstract]   [Full Text] [Related]  

  • 4. Systematic Review of Salivary Versus Blood Concentrations of Antituberculosis Drugs and Their Potential for Salivary Therapeutic Drug Monitoring.
    van den Elsen SHJ; Oostenbrink LM; Heysell SK; Hira D; Touw DJ; Akkerman OW; Bolhuis MS; Alffenaar JC
    Ther Drug Monit; 2018 Feb; 40(1):17-37. PubMed ID: 29120971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of oral fluid for therapeutic drug management: clinical and forensic toxicology.
    Langman LJ
    Ann N Y Acad Sci; 2007 Mar; 1098():145-66. PubMed ID: 17332075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of therapeutic drug monitoring of digoxin and gentamicin in the saliva of children.
    Berkovitch M; Bistritzer T; Aladjem M; Burtin P; Dagan T; Chen-Levi Z; Freedom R; Koren G
    Ther Drug Monit; 1998 Jun; 20(3):253-6. PubMed ID: 9631920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic drug monitoring in general practice--indications and interpretation].
    Bode-Böger SM; Böger RH; Frölich JC
    Z Arztl Fortbild (Jena); 1993 Mar; 87(3):201-10. PubMed ID: 8470405
    [No Abstract]   [Full Text] [Related]  

  • 8. Determination of tobramycin in saliva is not suitable for therapeutic drug monitoring of patients with cystic fibrosis.
    Madsen V; Lind A; Rasmussen M; Coulthard K
    J Cyst Fibros; 2004 Dec; 3(4):249-51. PubMed ID: 15698943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caffeine in saliva after peroral intake: early sample collection as a possible source of error.
    Biederbick W; Joseph G; Rump A; Theisohn M; Klaus W
    Ther Drug Monit; 1997 Oct; 19(5):521-4. PubMed ID: 9357094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disopyramide concentrations in human plasma and saliva: comparison of disopyramide concentrations in saliva and plasma unbound concentrations.
    Sagawa K; Mohri K; Shimada S; Shimizu M; Muramatsu J
    Eur J Clin Pharmacol; 1997; 52(1):65-9. PubMed ID: 9143870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dialysis-associated increase in the saliva level of paroxetine.
    Tsuruta T; Tanaka K; Ishikawa K; Yang C; Ueki H; Matsunaga M; Tatebayashi H; Yamada S
    J Clin Psychopharmacol; 2009 Dec; 29(6):619-20. PubMed ID: 19910739
    [No Abstract]   [Full Text] [Related]  

  • 12. Bioanalytical issues in patient-friendly sampling methods for therapeutic drug monitoring: focus on antiretroviral drugs.
    ter Heine R; Beijnen JH; Huitema AD
    Bioanalysis; 2009 Oct; 1(7):1329-38. PubMed ID: 21083054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic drug monitoring in oncology: does it have a future?
    McMahon G; O'Connor R
    Bioanalysis; 2009 Jun; 1(3):507-11. PubMed ID: 21083145
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug treatment during continuous haemofiltration.
    Evers J
    Intensive Care Med; 1994; 20(2):166. PubMed ID: 8201099
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic drug monitoring of antiepileptic drugs by use of saliva.
    Patsalos PN; Berry DJ
    Ther Drug Monit; 2013 Feb; 35(1):4-29. PubMed ID: 23288091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane Filtration Is Suitable for Reliable Elimination of Mycobacterium tuberculosis from Saliva for Therapeutic Drug Monitoring.
    van den Elsen SHJ; van der Laan T; Akkerman OW; van der Zanden AGM; Alffenaar JC; van Soolingen D
    J Clin Microbiol; 2017 Nov; 55(11):3292-3293. PubMed ID: 28794182
    [No Abstract]   [Full Text] [Related]  

  • 17. Interindividual and Intraindividual Variation of Methylphenidate Concentrations in Serum and Saliva of Patients With Attention-Deficit/Hyperactivity Disorder.
    Preiskorn J; Studer S; Rauh R; Lukačin R; Geffert C; Fleischhaker C; Clement HW; Schulz E; Biscaldi M
    Ther Drug Monit; 2018 Aug; 40(4):435-442. PubMed ID: 29750737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of saliva trough levels for monitoring voriconazole therapy in immunocompromised children and adults.
    Michael C; Bierbach U; Frenzel K; Lange T; Basara N; Niederwieser D; Mauz-Körholz C; Preiss R
    Ther Drug Monit; 2010 Apr; 32(2):194-9. PubMed ID: 20216120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral fluid as a diagnostic tool.
    Choo RE; Huestis MA
    Clin Chem Lab Med; 2004; 42(11):1273-87. PubMed ID: 15576290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of penetration of amikacin into saliva of tuberculosis patients.
    van den Elsen SHJ; Akkerman OW; Huisman JR; Touw DJ; van der Werf TS; Bolhuis MS; Alffenaar JC
    Eur Respir J; 2018 Jan; 51(1):. PubMed ID: 29326320
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.